-
My Account
In App
My Account
BSE Live
Dec 27, 11:22Prev. Close
4.50
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Key Financial Ratios of Vysali Pharmaceuticals (in Rs. Cr.) | Jun 07 | Mar 06 | Mar 05 | Mar 04 | |
| Per Share Ratios | |||||
| Basic EPS (Rs.) | 22.48 | -9.27 | -9.04 | -7.90 | |
| Diluted EPS (Rs.) | 22.48 | -9.27 | -9.04 | -7.90 | |
| Cash EPS (Rs.) | 23.29 | -8.63 | -8.40 | -7.21 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 21.54 | -25.50 | -16.21 | -7.18 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 21.54 | -25.50 | -16.21 | -7.18 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 18.69 | 9.42 | 12.82 | 14.66 | |
| PBDIT/Share (Rs.) | 0.07 | -8.34 | -7.83 | -4.93 | |
| PBIT/Share (Rs.) | -0.73 | -8.98 | -8.47 | -5.58 | |
| PBT/Share (Rs.) | -1.04 | -9.25 | -9.04 | -8.26 | |
| Net Profit/Share (Rs.) | 22.48 | -9.27 | -9.04 | -7.90 | |
| Profitability Ratios | |||||
| PBDIT Margin (%) | 0.38 | -88.51 | -61.06 | -33.60 | |
| PBIT Margin (%) | -3.91 | -95.34 | -66.09 | -38.02 | |
| PBT Margin (%) | -5.57 | -98.23 | -70.54 | -56.32 | |
| Net Profit Margin (%) | 120.29 | -98.44 | -70.54 | -53.89 | |
| Return on Networth / Equity (%) | 104.38 | 36.36 | 55.79 | 110.00 | |
| Return on Capital Employed (%) | 55.60 | -68.17 | -40.18 | -26.30 | |
| Return on Assets (%) | 45.05 | -41.83 | -28.36 | -20.24 | |
| Total Debt/Equity (X) | 0.88 | -1.53 | -2.39 | -5.31 | |
| Asset Turnover Ratio (%) | 37.45 | 42.49 | 40.20 | 37.56 | |
| Liquidity Ratios | |||||
| Current Ratio (X) | 2.03 | 1.79 | 2.60 | 3.43 | |
| Quick Ratio (X) | 0.69 | 0.25 | 0.66 | 0.56 | |
| Inventory Turnover Ratio (X) | 1.47 | 0.72 | 0.71 | 0.57 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 100.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 100.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | |||||
| Enterprise Value (Cr.) | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/EBITDA (X) | 0.00 | 0.00 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Retention Ratios (%) | 100.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Yield | 0.00 | 0.00 | 0.00 | 0.00 |
